| First Author | Kawano S | Year | 2022 |
| Journal | Biochem Biophys Res Commun | Volume | 605 |
| Pages | 45-50 | PubMed ID | 35313230 |
| Mgi Jnum | J:324233 | Mgi Id | MGI:7266147 |
| Doi | 10.1016/j.bbrc.2022.03.058 | Citation | Kawano S, et al. (2022) Autism-associated ANK2 regulates embryonic neurodevelopment. Biochem Biophys Res Commun 605:45-50 |
| abstractText | Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by altered social communication, restricted interests, and stereotypic behaviors. Although the molecular and cellular pathogeneses of ASD remain elusive, impaired neural stem cell differentiation and neuronal migration during cortical development are suggested to be critically involved in ASD. ANK2, which encodes for a cytoskeletal scaffolding protein involved in recruiting membrane proteins into specialized membrane domains, has been identified as a high-confidence ASD risk gene. However, the role of ANK2 in early neural development remains unclear. In this study, we analyzed the role of ANK2 in the cerebral cortex of developing mouse using in utero electroporation. We provide evidence suggesting that ANK2 regulates neural stem cell differentiation and neuronal migration in the embryonic cerebral cortex, where Ank2 is highly expressed. We also demonstrated that Ank2 knockdown alters the expression of genes involved in neural development. Taken together, these results support the view that ANK2 haploinsufficiency in patients may impair neural development, resulting in an increased risk of ASD. Our study findings provide new insights into the molecular and cellular pathogenesis of ASD, given that among high-confidence ASD genes, ANK2 is rare in that it encodes for a scaffolding protein for the membrane protein complex required for neuronal functions. |
